Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Cannabis Science Inc

+ Add to Watchlist

CXN:GR

0.026 EUR 0.002 7.14%

As of 15:43:45 ET on 05/22/2015.

Snapshot for Cannabis Science Inc (CXN)

Open: 0.027 Day's Range: 0.026 - 0.029 Volume: 100,500
Previous Close: 0.028 52wk Range: 0.026 - 0.100 1-Yr Rtn: -57.38%

Stock Chart for CXN

No chart data available.
  • CXN:GR 0.027
  • 1D
  • 1M
  • 1Y
0.028
Interactive CXN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CXN

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 30.82
Shares Outstanding (M) 1,185.21
30 Day Average Volume 149,553
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CXN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CXN

Cannabis Science Inc. is a scientific company involved in medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.

Raymond C DabneyPres/CEO/Co-FounderChad S JohnsonCOO/Secy/General Counsel
Richard OgdenChief Scientific OfficerRobert J Kane "Bob"VP:Investor Relations
More Company Profile & Key Executives for CXN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil